TY - JOUR
T1 - A Mouse with a Loss-of-function Mutation in the c-Cbl TKB Domain Shows Perturbed Thymocyte Signaling without Enhancing the Activity of the ZAP-70 Tyrosine Kinase
AU - Thien, Christine
AU - Scaife, Robin
AU - Papadimitriou, John
AU - Murphy, M.A.
AU - Bowtell, D.D.L.
AU - Langdon, Wallace
PY - 2003
Y1 - 2003
N2 - The unique tyrosine kinase binding (TKB) domain of Cb1 targets phosphorylated tyrosines on activated protein tyrosine kinases (PTKs); this targeting is considered essential for Cb1 proteins to negatively regulate PTKs. Here, a loss-of-function mutation (G304E) in the c-Cb1 TKB domain, first identified in Caenorhabditis elegans, was introduced into a mouse and its effects in thymocytes and T cells were studied. In marked contrast to the c-Cb1 knockout mouse, we found no evidence of enhanced activity of the ZAP-70 PTK in thymocytes from the TKB domain mutant mouse. This finding contradicts the accepted mechanism of c-Cb1-mediated negative regulation, which requires TKB domain targeting of phosphotyrosine 292 in ZAP-70. However, the TKB domain mutant mouse does show aspects of enhanced signaling that parallel those of the c-Cb1 knockout mouse, but these involve the constitutive activation of Rac and not enhanced PTK activity. Furthermore, the enhanced signaling in CD4(+)CD8(+) double positive thymocytes appears to be compensated by the selective down-regulation of CD3 on mature thymocytes and peripheral T cells from both strains of mutant c-Cb1 mice.
AB - The unique tyrosine kinase binding (TKB) domain of Cb1 targets phosphorylated tyrosines on activated protein tyrosine kinases (PTKs); this targeting is considered essential for Cb1 proteins to negatively regulate PTKs. Here, a loss-of-function mutation (G304E) in the c-Cb1 TKB domain, first identified in Caenorhabditis elegans, was introduced into a mouse and its effects in thymocytes and T cells were studied. In marked contrast to the c-Cb1 knockout mouse, we found no evidence of enhanced activity of the ZAP-70 PTK in thymocytes from the TKB domain mutant mouse. This finding contradicts the accepted mechanism of c-Cb1-mediated negative regulation, which requires TKB domain targeting of phosphotyrosine 292 in ZAP-70. However, the TKB domain mutant mouse does show aspects of enhanced signaling that parallel those of the c-Cb1 knockout mouse, but these involve the constitutive activation of Rac and not enhanced PTK activity. Furthermore, the enhanced signaling in CD4(+)CD8(+) double positive thymocytes appears to be compensated by the selective down-regulation of CD3 on mature thymocytes and peripheral T cells from both strains of mutant c-Cb1 mice.
U2 - 10.1084/jem.20021498
DO - 10.1084/jem.20021498
M3 - Article
SN - 0022-1007
VL - 197
SP - 503
EP - 513
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 4
ER -